The global Molecular Biology Enzymes, Reagents And Kits market size is expected to be worth around US$ 39.3 billion by 2030, according to a new report by Vision Research Reports.
The global Molecular Biology Enzymes, Reagents And Kits market size was valued at US$ 22.7 billion in 2020 and is anticipated to grow at a CAGR of 21.0 % during forecast period 2021 to 2030.
The molecular biology field holds great potential to advance the medical treatments based on increasing scientific knowledge of cellular processes coupled with improving access to proteomics and genomics data. Personal genome sequencing is also expected to gain traction in the development of tailored diagnostics for each patient. A confluence of these factors drives the demand for molecular biology enzymes, reagents, and kits in the expansion of advanced personalized treatments.
Market players are engaged in constant product launches to enhance the efficiency of existing techniques and generate molecular information more easily, rapidly, and accurately. For instance, in June 2020, PCR Biosystems introduced a 4x RT-qPCR kit, qPCRBIO Probe 1-Step Virus Detect, designed for high-throughput, ultra-sensitive detection of viral RNA sequences, such as coronavirus. This new kit is proven to offer successful research in diagnostic projects.
Besides, is a rapidly advancing biotechnology field, which applies robust, innovative methods for drug manufacturing, cell therapies, and clinical diagnostics. Funding initiatives in this field expand its applications, which boost the usage of molecular biology products in these applications. As per SynBioBeta data, 37 synthetic biology companies raised USD 1.2 billion in the second quarter and 65 synthetic biology firms received USD 1.9 million funding in the first quarter of 2019.
Kits and reagents dominated the market for molecular biology enzymes and reagents and kits with a revenue share of 68.5% in 2019. This is due to the wide availability of kits and reagents and novel product developments by key companies. For instance, in March 2019, Asuragen, Inc. introduced the AmplideX PCR/CE SMN1/2 Kit that offers a reliable and rapid technique for the detection of SMN2 and SMN1 exon 7 copy number within 4 hours. It is based on a Polymerase Chain Reaction (PCR) and is used for molecular diagnostic purposes.
An exponential rise in the number of COVID-19 cases globally has encouraged biotechnology and healthcare companies to accelerate the production of RT-PCR-based testing kits. As reported in March 2020, Thermo Fisher stated that it has planned to generate up to 5.0 million new tests for the detection of COVID-19. Therefore, an increase in the commercial availability of COVID-19 testing products is expected to drive the demand for kits and reagents used in COVID-19 diagnosis. Enzymes such as Proteinases are used in the diagnosis and have gained momentum as a consequence of the pandemic.
Furthermore, the continuous expansion of cloning technology as a routine laboratory technology has allowed manufacturers to provide numerous enzymes for the generation and manipulation of nucleic acids. This technology has progressed from single DNA fragment cloning to the assembly of multiple DNA fragments into a single contiguous DNA stretch. Therefore, advancement in cloning technology influences the growth of molecular biology enzymes at a lucrative pace during the forecast period.
The sequencing segment accounted for the major revenue share of 34.9% in 2019 in the molecular biology enzymes, reagents and kits market. The segment is expected to grow at a lucrative pace. With the introduction of (NGS), there has been tremendous progress in genetic research and the discovery of human diseases. NGS analysis of tumor epigenomics, genomics, and transcriptomics, drives biomarker discovery for cancer diagnostics and tumor stratification.
The benefits of NGS include detection of the smallest possible mutation, easier combined detection of SNP and larger abnormalities, and most important combination of high-throughput, speed, and resolution. Moreover, a rise in the adoption of personalized medicine through targeted and whole-exome sequencing is expected to drive the demand for sequencing. Thereby, widespread adoption of these technologies accelerates the utilization of molecular biology products under this segment.
In terms of revenue, PCR captured the second-largest revenue share in 2019 in the market for molecular biology enzymes, reagents, and kits. The advent of miniPCR in recent times has made the technique affordable and more portable. On the other hand, the introduction of the droplet digital PCR (ddPCR), which integrates conventional PCR with the fluorescence-activated cell sorting aspects, offers a highly automated and robust technology for the detection of scarce targets in samples. Such advances in PCR technology are expected to drive revenue in this segment.
The pharma and biotech segment dominated the market for molecular biology enzymes and reagents and kits and accounted for the largest revenue share of 36.3% in 2019. An increase in the R&D activities and several ongoing clinical trials in the pharma and biotech firms are driving the demand for molecular biology enzymes and reagents. Furthermore, shifting preferences towards personalized medicine and companion diagnostic has propelled collaborations and mergers with respect to sequencing technology, which subsequently surges the demand for sequencing products.
For instance, QIAGEN entered into a 15-year partnership with Illumina, Inc. to broaden the use of NGS-based in vitro diagnostic kits for patient management in October 2019. This collaboration offers QIAGEN with an opportunity to develop companion diagnostic tests for the evaluation of tumors for potential immunotherapies on the TruSight Oncology assays from Illumina. Such initiatives are also expected to fuel the segment growth at a lucrative pace in the market for molecular biology enzymes, reagents, and kits.
Wide applications of NGS and PCR techniques in academic research projects accelerate the uptake of these products by universities and research centers. As reported in March 2020, researchers at the UNC Medical Center Microbiology and Molecular Microbiology Laboratories explored the usage of NGS for accurate COVID-19 diagnosis. Moreover, arise in funding and investment for these entities are expected to augment the academic and research segment at a considerable CAGR.
North America dominated the market for molecular biology enzymes, reagents, and kits and accounted for the largest revenue share of 45.5% in 2019. Initiatives, such as the Newborn Sequencing in Genomic Medicine and Public Health program by the National Human Genome Research Institute to screen infants for genetic diseases, boost the implementation of NGS technology and its associated reagents and kits.
The U.S.-based companies are undertaking focused efforts to develop technologically advanced products for molecular biology techniques that consequently drive the market for molecular biology enzymes, reagents, and kits in the region. For instance, in May 2019, Pharmozyme, Inc., launched Crystal Taq, which is a cost-effective solution with improved test accuracy. This is the first Taq Polymerase enzyme free from bacterial and animal DNA contamination and reduces PCR background contamination.
In the Asia Pacific, the market for molecular biology enzymes, reagents, and kits is projected to register a lucrative growth rate during the forecast period. Continual development and commercialization of point of care PCR equipment and reagents by the regional players are one of the primary factors influencing the growth of the market in the region. For instance, in May 2020, Fujifilm Wako Pure Chemical Corp., a Japan-based firm, initiated the commercialization of PCR reagents for the automated coronavirus test device.
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
New England Biolabs
Takara Bio, Inc.
Kits & Reagents
Pharma & Biotech
Academic & Research
Hospital & Diagnostics
Middle East & Africa (MEA)
The Molecular Biology Enzymes, Reagents And Kits market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Molecular Biology Enzymes, Reagents And Kits market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Molecular Biology Enzymes, Reagents And Kits market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Biology Enzymes, Reagents And Kits market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Molecular Biology Enzymes, Reagents And Kits market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Molecular Biology Enzymes, Reagents And Kits capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Molecular Biology Enzymes, Reagents And Kits by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Molecular Biology Enzymes, Reagents And Kits market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Molecular Biology Enzymes, Reagents And Kits market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Molecular Biology Enzymes, Reagents And Kits market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Molecular Biology Enzymes, Reagents And Kits industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Molecular Biology Enzymes, Reagents And Kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Molecular Biology Enzymes, Reagents And Kits market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Molecular Biology Enzymes, Reagents And Kits market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Molecular Biology Enzymes, Reagents And Kits market. These factors have benefited the growth of the global market for Molecular Biology Enzymes, Reagents And Kits. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Molecular Biology Enzymes, Reagents And Kits. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Molecular Biology Enzymes, Reagents And Kits are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Orthopedic Soft Tissue Repair Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Coagulation Analyzer Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Biological Implants Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Automated Dispensing Machines Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Neurodiagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...